CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-14 | Tobin Bernard President Crescendo BioScience | Grant or award | +49,608 | 86,220 | ||
| 2016-09-14 | Tobin Bernard President Crescendo BioScience | Grant or award | +40,000 | 126,220 | ||
| 2016-09-14 | Riggsbee Richard Bryan Chief Financial Officer | Grant or award | +47,700 | 75,273 | ||
| 2016-09-14 | McDade Ralph L President Myriad RBM, Inc. | Grant or award | +30,000 | 86,720 | ||
| 2016-09-14 | Drosos Virginia President Assurex Health | Grant or award | +50,000 | 50,000 | ||
| 2016-09-14 | King Gary A. Exec. VP International Ops | Grant or award | +30,000 | 111,220 | ||
| 2016-09-14 | Capone Mark Christopher President & C.E.O. | Grant or award | +78,705 | 224,731 | ||
| 2016-09-14 | LANCHBURY JERRY S Chief Scientific Officer | Grant or award | +46,508 | 117,245 | ||
| 2016-09-14 | MARSH RICHARD M E.V.P., General Counsel | Grant or award | +45,077 | 118,386 | ||
| 2016-09-12 | HENDERSON JOHN T Director | Exercise or conversion | +2,007 | $10.60 | $21K | 23,507 |
| 2016-09-12 | HENDERSON JOHN T Director | Sale | −2,007 | $20.21 | $41K | 21,500 |
| 2016-09-12 | HENDERSON JOHN T Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,007 | 0 | ||
| 2016-09-09 | HENDERSON JOHN T Director | Exercise or conversion | +27,993 | $10.60 | $297K | 49,493 |
| 2016-09-09 | HENDERSON JOHN T Director | Sale | −27,993 | $20.51 | $574K | 21,500 |
| 2016-09-09 | HENDERSON JOHN T Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −27,993 | 2,007 | ||
| 2016-08-19 | Capone Mark Christopher President & C.E.O. | Purchase | +10,000 | $21.24 | $212K | 146,026 |
| 2016-08-12 | McDade Ralph L President Myriad RBM, Inc. | Purchase | +1,000 | $21.49 | $21K | 56,720 |
| 2016-06-21 | Ford Alexander President, MGL | Exercise or conversion | +5,449 | $19.47 | $106K | 40,122 |
| 2016-06-21 | Ford Alexander President, MGL | Sale | −5,449 | $30.88 | $168K | 34,673 |
| 2016-06-21 | Ford Alexander President, MGL | Exercise or conversion | +11,000 | $18.00 | $198K | 45,673 |
Page 49 of 60 · 1,194 trades